Month: August 2018

Notizia

Business Consultant, Notizia, Pharma Consultant

Kalydeco, the first Cystic Fibrosis drug of Vertex, got approved for infants The Food and Drug Administration has cleared Kalydeco drug of...

Read More

Idiopathic Pulmonary Fibrosis (IPF) – When to start and what is coming in the race to treat the deadlier constricts….

Business Consultant, Pharma Consultant

Idiopathic Pulmonary Fibrosis (IPF) is a debilitating, chronic, fatal disease with an excess fibrous tissue called as fibrosis in the...

Read More

KEY CLINICAL OUTCOMES

Articles, Business Consultant, Pharma Consultant

Bexion Pharmaceuticals’ Early-Stage Cancer Drug, BXQ-350 Hailed as Game Changer For the Treatment of solid tumors and gliomas Bexion...

Read More

Regulatory

Articles

Alnylam’s Onpattro Receives First-Ever US FDA Approval for Treatment of the Polyneuropathy of Hereditary Transthyretin-Mediated...

Read More

The Business Cocktail(Therapeutics)

Business Consultant, Pharma Consultant, The Business Cocktail

Blueberry Therapeutics reels in USD 12.7 Million in series B funding for fungal infections. U.K.based, Blueberry...

Read More

Personalized Medicine Approach: An Upholding Paradigm for a Promising and futuristic Patient Centric Health Care

Articles

Personalized Medicine (also referred as Precision Medicine) is a tailored approach of deciding and predicting treatment practices based on...

Read More
Close